| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 767991 | 113818009 | BOSULIF 100 MG CAPSULAS DURAS | BOSULIF 100 MG CAPSULAS DURAS, 150 cápsulas | 100 mg | 6 | 150 | 58 | 150 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113818009/113818009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113818009/113818009_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2025-06-23 | 1 | 1 | 1 | 2025-06-24 | 2025-06-23 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 697792 | 113818001 | BOSULIF 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | BOSULIF 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 100 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113818001/113818001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113818001/113818001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2013-04-24 | 1 | 1 | 1 | 2013-04-24 | 2013-04-24 | 1 | 2017-03-08 | View Edit Delete | ||||||||||||
| 721958 | 113818006 | BOSULIF 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | BOSULIF 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 400 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113818006/113818006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113818006/113818006_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2018-06-05 | 1 | 1 | 1 | 2018-06-06 | 2018-06-05 | 1 | 2021-03-12 | View Edit Delete | ||||||||||||
| 767990 | 113818008 | BOSULIF 50 MG CAPSULAS DURAS | BOSULIF 50 MG CAPSULAS DURAS, 30 cápsulas | 50 mg | 6 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113818008/113818008_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113818008/113818008_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2025-06-23 | 1 | 1 | 1 | 2025-06-24 | 2025-06-23 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 697793 | 113818003 | BOSULIF 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | BOSULIF 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 500 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113818003/113818003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113818003/113818003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2013-04-24 | 1 | 1 | 1 | 2013-04-24 | 2013-04-24 | 1 | 2017-03-08 | View Edit Delete | ||||||||||||
| 764560 | 89447 | BOSUTINIB DR. REDDYS 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSUTINIB DR. REDDYS 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 100 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89447/89447_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89447/89447_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27152 | REDDY PHARMA IBERIA S.A. | 2024-03-18 | 1 | 1 | 1 | 2024-03-19 | 2024-03-18 | 1 | 2024-08-12 | View Edit Delete | ||||||||||||
| 764561 | 89448 | BOSUTINIB DR. REDDYS 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSUTINIB DR. REDDYS 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 400 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89448/89448_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89448/89448_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27152 | REDDY PHARMA IBERIA S.A. | 2024-03-18 | 1 | 1 | 1 | 2024-03-19 | 2024-03-18 | 1 | 2024-08-12 | View Edit Delete | ||||||||||||
| 764562 | 89449 | BOSUTINIB DR. REDDYS 500 COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSUTINIB DR. REDDYS 500 COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 500 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89449/89449_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89449/89449_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27152 | REDDY PHARMA IBERIA S.A. | 2024-03-18 | 1 | 1 | 1 | 2024-03-19 | 2024-03-18 | 1 | 2024-08-12 | View Edit Delete | ||||||||||||
| 764409 | 89383 | BOSUTINIB STADA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSUTINIB STADA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 100 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89383/89383_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89383/89383_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2024-02-26 | 1 | 1 | 1 | 2024-02-27 | 2024-02-26 | 1 | 2024-08-12 | View Edit Delete | ||||||||||||
| 764410 | 89384 | BOSUTINIB STADA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSUTINIB STADA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 400 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89384/89384_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89384/89384_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2024-02-26 | 1 | 1 | 1 | 2024-02-27 | 2024-02-26 | 1 | 2024-08-12 | View Edit Delete | ||||||||||||
| 764411 | 89385 | BOSUTINIB STADA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSUTINIB STADA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 500 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89385/89385_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89385/89385_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2024-02-26 | 1 | 1 | 1 | 2024-02-27 | 2024-02-26 | 1 | 2024-08-12 | View Edit Delete | ||||||||||||
| 767997 | 90410 | BOSUTINIB VIVANTA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSUTINIB VIVANTA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 100 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90410/90410_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90410/90410_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27271 | VIVANTA GENERICS S.R.O. SUCURSAL EN ESPANA | 2025-06-26 | 1 | 1 | 1 | 2025-06-27 | 2025-06-26 | 0 | 2025-08-27 | View Edit Delete | ||||||||||||
| 767998 | 90411 | BOSUTINIB VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSUTINIB VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 400 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90411/90411_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90411/90411_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27271 | VIVANTA GENERICS S.R.O. SUCURSAL EN ESPANA | 2025-06-26 | 1 | 1 | 1 | 2025-06-27 | 2025-06-26 | 0 | 2025-08-27 | View Edit Delete | ||||||||||||
| 767999 | 90409 | BOSUTINIB VIVANTA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSUTINIB VIVANTA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 500 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90409/90409_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90409/90409_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27271 | VIVANTA GENERICS S.R.O. SUCURSAL EN ESPANA | 2025-06-26 | 1 | 1 | 1 | 2025-06-27 | 2025-06-26 | 0 | 2025-08-27 | View Edit Delete | ||||||||||||
| 764682 | 89483 | BOSUTINIB ZENTIVA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSUTINIB ZENTIVA 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 100 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89483/89483_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89483/89483_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8183 | ZENTIVA SPAIN S.L. | 2024-04-09 | 1 | 1 | 1 | 2024-04-10 | 2024-04-09 | 1 | 2024-10-15 | View Edit Delete | ||||||||||||
| 764683 | 89484 | BOSUTINIB ZENTIVA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSUTINIB ZENTIVA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 400 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89484/89484_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89484/89484_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8183 | ZENTIVA SPAIN S.L. | 2024-04-09 | 1 | 1 | 1 | 2024-04-10 | 2024-04-09 | 1 | 2024-10-15 | View Edit Delete | ||||||||||||
| 764684 | 89482 | BOSUTINIB ZENTIVA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSUTINIB ZENTIVA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 500 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89482/89482_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89482/89482_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8183 | ZENTIVA SPAIN S.L. | 2024-04-09 | 1 | 1 | 1 | 2024-04-10 | 2024-04-09 | 1 | 2024-10-15 | View Edit Delete | ||||||||||||
| 888172 | 63194 | BOTOX 100 UNIDADES ALLERGAN, POLVO PARA SOLUCIÓN INYECTABLE | BOTOX 100 UNIDADES ALLERGAN, POLVO PARA SOLUCIÓN INYECTABLE , 1 vial | 100 U | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63194/63194_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63194/63194_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16052 | ABBVIE SPAIN, S.L.U. | 2000-06-27 | 1 | 1 | 1 | 2000-06-27 | 2000-06-27 | 1 | 2011-11-21 | View Edit Delete | ||||||||||||
| 605424 | 63194 | BOTOX 100 UNIDADES ALLERGAN, POLVO PARA SOLUCIÓN INYECTABLE | BOTOX 100 UNIDADES ALLERGAN, POLVO PARA SOLUCIÓN INYECTABLE , 10 viales | 100 U | 45 | 10 | 34 | 10 viales | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63194/63194_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63194/63194_p.pdf | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 16052 | ABBVIE SPAIN, S.L.U. | 2000-06-27 | 1 | 1 | 1 | 2000-06-27 | 2011-05-10 | 1 | 2011-12-14 | View Edit Delete | ||||||||||||
| 670615 | 72377 | BOTOX 200 UNIDADES ALLERGAN, POLVO PARA SOLUCIÓN INYECTABLE | BOTOX 200 UNIDADES ALLERGAN, POLVO PARA SOLUCIÓN INYECTABLE , 1 vial | 200 U | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72377/72377_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72377/72377_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16052 | ABBVIE SPAIN, S.L.U. | 2011-04-08 | 1 | 1 | 1 | 2011-04-08 | 2011-04-08 | 1 | 2018-02-14 | View Edit Delete |
Page 148 of 1035, showing 20 records out of 20697 total, starting on record 2941, ending on 2960